SAWAI GROUP HOLDINGS Co., Ltd. (4887) Cash flow
Market cap
¥221.9B
P/E ratio
10.5x
Sawai Group Holdings manufactures and sells prescription and over-the-counter pharmaceuticals through its domestic subsidiaries in Japan.
| 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 17,045 | 17,683 | 18,055 | 15,241 | 16,002 |
| Cash from operations | 34,310 | 13,026 | 23,149 | 27,851 | 7,433 |
| Capital expenditures | -14,513 | -20,727 | -17,915 | -20,567 | -13,416 |
| Cash from investing | -30,395 | -27,134 | -23,112 | 6,480 | -22,898 |
| Payments for dividends | -5,693 | -5,693 | -5,694 | -6,070 | -6,235 |
| Repurchases of common stock | - | - | - | -33,320 | - |
| Proceeds from issuance of term debt, net | - | 9,500 | - | 35,036 | 20,500 |
| Repayments of term debt | -3,834 | -3,118 | -3,034 | -30,858 | -14,971 |
| Cash from financing | -11,262 | -1,267 | 2,363 | -32,704 | 5,587 |